Harvard Business Review
JUNE 16, 2011
So it is with most breakthrough innovations and banner financial years. Interestingly, intangible assets are all the rage these days on Wall Street. There is no line on the balance sheet for "ability to innovate" or "skill at managing brand." If ego and time allow, the list can be quite long.
Harvard Business Review
NOVEMBER 21, 2013
Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. Why do some companies choose to patent their innovation while others choose to hide it? When facing the choice of patenting or hiding a valuable innovation, you must first ask yourself whether the invention is patentable at all.
Expert insights. Personalized for you.
15 
Let's personalize your content